Literature DB >> 30153431

Maternal age and risk for adverse outcomes.

Jean-Ju Sheen1, Jason D Wright1, Dena Goffman1, Adina R Kern-Goldberger1, Whitney Booker1, Zainab Siddiq1, Mary E D'Alton1, Alexander M Friedman2.   

Abstract

OBJECTIVE: The objective of this study was to characterize the risk for severe maternal morbidity and other pregnancy complications by maternal age during delivery hospitalizations. STUDY
DESIGN: This retrospective cohort analysis used the Perspective database to characterize the risk for adverse maternal outcomes from 2006 to 2015 based on maternal age. Women were divided into 7 categories based on maternal age: 15-17, 18-24, 25-29, 30-34, 35-39, 40-44, and 45-54 years of age. The primary outcome of this study was severe maternal morbidity as defined by the Centers for Disease Control and Prevention. Secondary outcomes included (1) overall comorbid risk; (2) risk for pregnancy complications such as postpartum hemorrhage, gestational diabetes, preeclampsia, and cesarean delivery; and (3) risk for individual severe morbidity diagnoses such as stroke, embolism, eclampsia, and hysterectomy. Adjusted models were fitted to assess factors associated with severe morbidity with adjusted risk ratios (aRRs) and 95% confidence intervals (CI) as measures of effect. Population weights were applied to create national estimates.
RESULTS: Of 36,944,292 deliveries included, 2.5% occurred among women aged 15-17 years (n = 921,236), 29.1% to women aged 18-24 years (n = 10,732,715), 28.6% to women aged 25-29 years (n = 10,564,850), 24.9% to women aged 30-34 years (n = 9,213,227), 12.1% to women aged 35-39 years (n = 4,479,236), 2.6% to women aged 40-44 years (n = 974,289), and 0.2% to women aged 45-54 years (n = 58,739). In unadjusted analyses, severe morbidity was more than 3 times higher (risk ratio [RR], 3.33, 95% confidence interval [CI], 3.03-3.66) for women 45-54 years compared with women 25-29 years. Women aged 40-44, 35-39, and 15-17 years were also at increased risk (RR, 1.83, 95% CI, 1.77-1.89; RR, 1.36, 95% CI, 1.33-1.39; RR, 1.39, 95% CI, 1.34-1.45, respectively). In the adjusted model, the 45-54 year old group was associated with the highest relative risk (aRR, 3.46, 95% CI, 3.15-3.80) followed by the 40-44 year old group (aRR 1.90, 95% CI, 1.84-1.97), the 35-39 year old group (aRR, 1.43, 95% CI, 1.40-1.47), and the 15-17 year old group (aRR, 1.20, 95% CI, 1.15-1.24). Cesarean delivery, preeclampsia, postpartum hemorrhage, and gestational diabetes were most common among women aged 45-54 years, as were thrombosis and hysterectomy.
CONCLUSION: While differential risk was noted across maternal age categories, women aged 45 years old and older were at highest risk for a broad range of adverse outcomes during delivery hospitalizations.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  maternal risk; severe morbidity; very advanced maternal age

Mesh:

Year:  2018        PMID: 30153431     DOI: 10.1016/j.ajog.2018.08.034

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  31 in total

1.  Relationship Between Depression and/or Anxiety and Hospital Readmission Among Women After Childbirth.

Authors:  Aparna Kumar; Aditi Rao; Kathleen O'Rourke; Nancy Hanrahan
Journal:  J Obstet Gynecol Neonatal Nurs       Date:  2019-07-26

2.  Age-associated changes in cumulus cells and follicular fluid: the local oocyte microenvironment as a determinant of gamete quality.

Authors:  Elnur Babayev; Francesca E Duncan
Journal:  Biol Reprod       Date:  2022-02-22       Impact factor: 4.285

3.  Is advanced maternal age associated with placental vascular malperfusion? A prospective study from a single tertiary center.

Authors:  Hadas Miremerg; Omry Frig; Shiran Rona; Hadas Ganer Herman; Yossi Mizrachi; Letizia Schreiber; Jacob Bar; Michal Kovo; Eran Weiner
Journal:  Arch Gynecol Obstet       Date:  2020-05-03       Impact factor: 2.344

Review 4.  Maternal Stroke: A Call for Action.

Authors:  Islam Y Elgendy; Syed Bukhari; Amr F Barakat; Carl J Pepine; Kathryn J Lindley; Eliza C Miller
Journal:  Circulation       Date:  2021-02-15       Impact factor: 29.690

Review 5.  Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics.

Authors:  Eliza C Miller; Ashley Wilczek; Natalie A Bello; Sarah Tom; Ronald Wapner; Yousin Suh
Journal:  Ageing Res Rev       Date:  2021-12-03       Impact factor: 10.895

Review 6.  Cardiovascular Outcomes in Advanced Maternal Age Delivering Women. Clinical Review and Medico-Legal Issues.

Authors:  Daniele De Viti; Antonio Malvasi; Francesco Busardò; Renata Beck; Simona Zaami; Enrico Marinelli
Journal:  Medicina (Kaunas)       Date:  2019-09-29       Impact factor: 2.430

7.  Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.

Authors:  Oludare A Odumade; Alec L Plotkin; Jensen Pak; Olubukola T Idoko; Matthew A Pettengill; Tobias R Kollmann; Al Ozonoff; Beate Kampmann; Ofer Levy; Kinga K Smolen
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

8.  Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.

Authors:  Hee-Sung Ahn; Jung Yoon Ho; Jiyoung Yu; Jeonghun Yeom; Sanha Lee; Soo Young Hur; Yuyeon Jung; Kyunggon Kim; Youn Jin Choi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

9.  Pregnancy at 40 years Old and Above: Obstetrical, Fetal, and Neonatal Outcomes. Is Age an Independent Risk Factor for Those Complications?

Authors:  Ana Bouzaglou; Ines Aubenas; Hind Abbou; Stephanie Rouanet; Marie Carbonnel; Paul Pirtea; Jean Marc Bernard Ayoubi
Journal:  Front Med (Lausanne)       Date:  2020-05-27

10.  Maternal Race/Ethnicity, Hypertension, and Risk for Stroke During Delivery Admission.

Authors:  Eliza C Miller; Maria Daniela Zambrano Espinoza; Yongmei Huang; Alexander M Friedman; Amelia K Boehme; Natalie A Bello; Kirsten L Cleary; Jason D Wright; Mary E D'Alton
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.